Salveen Richter
Stock Analyst at Goldman Sachs
(2.31)
# 2,554
Out of 4,868 analysts
205
Total ratings
41.74%
Success rate
-2.1%
Average return
Main Sectors:
Stocks Rated by Salveen Richter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SRPT Sarepta Therapeutics | Downgrades: Neutral | $29 | $20.77 | +39.62% | 5 | Jun 17, 2025 | |
| ELVN Enliven Therapeutics | Initiates: Buy | $37 | $21.57 | +71.53% | 1 | Jun 16, 2025 | |
| FDMT 4D Molecular Therapeutics | Maintains: Buy | $51 → $44 | $4.09 | +975.79% | 4 | May 9, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Neutral | $53 → $47 | $44.43 | +5.78% | 4 | May 8, 2025 | |
| RCUS Arcus Biosciences | Maintains: Neutral | $15 → $13 | $8.51 | +52.76% | 3 | May 8, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Buy | $124 → $104 | $55.24 | +88.27% | 1 | May 5, 2025 | |
| SMMT Summit Therapeutics | Maintains: Buy | $37 → $41 | $20.16 | +103.37% | 2 | May 2, 2025 | |
| FOLD Amicus Therapeutics | Maintains: Neutral | $12 → $9 | $5.73 | +57.07% | 2 | May 2, 2025 | |
| ADPT Adaptive Biotechnologies | Maintains: Buy | $9 → $10 | $10.47 | -4.49% | 11 | May 2, 2025 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $917 → $804 | $513.58 | +56.55% | 11 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $219 → $197 | $126.54 | +55.68% | 4 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $36 → $32 | $17.76 | +80.18% | 8 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $18 | $3.36 | +435.71% | 3 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $85 → $96 | $108.00 | -11.11% | 5 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $99 → $51 | $25.40 | +100.79% | 10 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $40 | $14.09 | +183.89% | 5 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $12 | $9.60 | +25.00% | 8 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $20 | $15.10 | +32.45% | 7 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $63 → $70 | $68.27 | +2.53% | 9 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $198 → $370 | $312.32 | +18.47% | 5 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $67 → $76 | $37.35 | +103.48% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $33 → $37 | $37.01 | -0.03% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $19 → $11 | $9.13 | +20.48% | 11 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $33 → $53 | $35.46 | +49.46% | 9 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $313 → $350 | $289.63 | +20.84% | 7 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $442 → $559 | $448.40 | +24.67% | 4 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4.5 → $5 | $12.70 | -60.63% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $31 | $1.29 | +2,303.10% | 7 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $257 → $225 | $295.19 | -23.78% | 1 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $22 | $1.80 | +1,122.22% | 1 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $9.58 | - | 4 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $4.70 | +538.30% | 5 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $14 | $0.87 | +1,514.58% | 3 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $9 | $5.11 | +76.13% | 6 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $16 → $3 | $2.57 | +16.73% | 4 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $15 → $12 | $22.91 | -47.62% | 8 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $6 | $2.76 | +117.39% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $39 → $43 | $52.76 | -18.50% | 1 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $3 → $2 | $1.40 | +42.86% | 3 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $125 → $100 | $8.02 | +1,146.88% | 1 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $28 → $30 | $0.39 | +7,582.46% | 3 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $57 → $50 | $90.72 | -44.89% | 4 | Mar 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $45 | $15.62 | +188.09% | 1 | Mar 17, 2020 |
Sarepta Therapeutics
Jun 17, 2025
Downgrades: Neutral
Price Target: $29
Current: $20.77
Upside: +39.62%
Enliven Therapeutics
Jun 16, 2025
Initiates: Buy
Price Target: $37
Current: $21.57
Upside: +71.53%
4D Molecular Therapeutics
May 9, 2025
Maintains: Buy
Price Target: $51 → $44
Current: $4.09
Upside: +975.79%
CRISPR Therapeutics AG
May 8, 2025
Maintains: Neutral
Price Target: $53 → $47
Current: $44.43
Upside: +5.78%
Arcus Biosciences
May 8, 2025
Maintains: Neutral
Price Target: $15 → $13
Current: $8.51
Upside: +52.76%
BioMarin Pharmaceutical
May 5, 2025
Maintains: Buy
Price Target: $124 → $104
Current: $55.24
Upside: +88.27%
Summit Therapeutics
May 2, 2025
Maintains: Buy
Price Target: $37 → $41
Current: $20.16
Upside: +103.37%
Amicus Therapeutics
May 2, 2025
Maintains: Neutral
Price Target: $12 → $9
Current: $5.73
Upside: +57.07%
Adaptive Biotechnologies
May 2, 2025
Maintains: Buy
Price Target: $9 → $10
Current: $10.47
Upside: -4.49%
Regeneron Pharmaceuticals
Apr 30, 2025
Maintains: Buy
Price Target: $917 → $804
Current: $513.58
Upside: +56.55%
Apr 23, 2025
Maintains: Buy
Price Target: $219 → $197
Current: $126.54
Upside: +55.68%
Mar 3, 2025
Maintains: Neutral
Price Target: $36 → $32
Current: $17.76
Upside: +80.18%
Feb 27, 2025
Maintains: Buy
Price Target: $20 → $18
Current: $3.36
Upside: +435.71%
Feb 12, 2025
Maintains: Neutral
Price Target: $85 → $96
Current: $108.00
Upside: -11.11%
Jan 29, 2025
Downgrades: Neutral
Price Target: $99 → $51
Current: $25.40
Upside: +100.79%
Jan 28, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $14.09
Upside: +183.89%
Jan 14, 2025
Maintains: Neutral
Price Target: $20 → $12
Current: $9.60
Upside: +25.00%
Dec 12, 2024
Maintains: Neutral
Price Target: $9 → $20
Current: $15.10
Upside: +32.45%
Oct 30, 2024
Maintains: Neutral
Price Target: $63 → $70
Current: $68.27
Upside: +2.53%
Aug 16, 2024
Upgrades: Buy
Price Target: $198 → $370
Current: $312.32
Upside: +18.47%
Aug 2, 2024
Maintains: Buy
Price Target: $67 → $76
Current: $37.35
Upside: +103.48%
Aug 2, 2024
Maintains: Sell
Price Target: $33 → $37
Current: $37.01
Upside: -0.03%
Jul 26, 2024
Maintains: Neutral
Price Target: $19 → $11
Current: $9.13
Upside: +20.48%
Jun 4, 2024
Maintains: Neutral
Price Target: $33 → $53
Current: $35.46
Upside: +49.46%
Feb 8, 2024
Maintains: Buy
Price Target: $313 → $350
Current: $289.63
Upside: +20.84%
Jan 31, 2024
Maintains: Buy
Price Target: $442 → $559
Current: $448.40
Upside: +24.67%
Aug 15, 2023
Maintains: Neutral
Price Target: $4.5 → $5
Current: $12.70
Upside: -60.63%
Mar 2, 2023
Maintains: Buy
Price Target: $35 → $31
Current: $1.29
Upside: +2,303.10%
Feb 24, 2023
Maintains: Overweight
Price Target: $257 → $225
Current: $295.19
Upside: -23.78%
Nov 14, 2022
Initiates: Neutral
Price Target: $22
Current: $1.80
Upside: +1,122.22%
Nov 11, 2022
Downgrades: Neutral
Price Target: n/a
Current: $9.58
Upside: -
Nov 10, 2022
Maintains: Neutral
Price Target: $60 → $30
Current: $4.70
Upside: +538.30%
Nov 10, 2022
Maintains: Buy
Price Target: $25 → $14
Current: $0.87
Upside: +1,514.58%
Nov 9, 2022
Maintains: Neutral
Price Target: $8 → $9
Current: $5.11
Upside: +76.13%
Nov 9, 2022
Downgrades: Neutral
Price Target: $16 → $3
Current: $2.57
Upside: +16.73%
Nov 4, 2022
Downgrades: Sell
Price Target: $15 → $12
Current: $22.91
Upside: -47.62%
Nov 3, 2022
Maintains: Neutral
Price Target: $7 → $6
Current: $2.76
Upside: +117.39%
Oct 28, 2022
Maintains: Neutral
Price Target: $39 → $43
Current: $52.76
Upside: -18.50%
May 24, 2022
Maintains: Sell
Price Target: $3 → $2
Current: $1.40
Upside: +42.86%
May 24, 2022
Maintains: Sell
Price Target: $125 → $100
Current: $8.02
Upside: +1,146.88%
Mar 4, 2021
Upgrades: Buy
Price Target: $28 → $30
Current: $0.39
Upside: +7,582.46%
Mar 19, 2020
Maintains: Neutral
Price Target: $57 → $50
Current: $90.72
Upside: -44.89%
Mar 17, 2020
Initiates: Neutral
Price Target: $45
Current: $15.62
Upside: +188.09%